Skip to main content

KdT Ventures — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

57
Companies
$546.9M
Total invested
$12.7M
Avg. check
35
Industries
Biotechnology 15Health Care 11Medical 11Therapeutics 6Life Science 5Artificial Intelligence (AI) 4+29 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 57
Transcera
July 2023

Transcera is a biotechnology company that uses a new approach to biological drug delivery to transform the treatment of chronic diseases.

Biotechnology · Jamaica PlainSeed
Modulus Therapeutics
July 2021

Modulus Therapeutics is an artificial-intelligence-powered cell therapy design company.

Artificial Intelligence (AI) · Seattle$3.5M Seed
Rejuvenate Bio
June 2026

Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.

Biotechnology · San Diego$6.0M Venture - Series Unknown
Montara Therapeutics
June 2026

Montara Therapeutics offers a platform to prevent peripheral toxicities and concentrate neurological drugs’ activity in the brain.

Biopharma · San Francisco$1.0M Grant
PHNX Materials
April 2025

PHNX Materials is a manufacturing company that specializes in turning waste into essential materials and reduce carbon emissions.

Environmental Engineering · San Francisco$2.5M Seed
Tacit Therapeutics
March 2026

Tacit Therapeutics created RNA-targeting treatments for devastating diseases.

Biotechnology · South San Francisco$19.0M Series A
MacroCycle Technologies
March 2026

MacroCycle Technologies is a cleantech company that develops sustainable and zero-carbon plastic upcycling solutions.

CleanTech · Cambridge$3.0M Seed
Unravel Biosciences
March 2023

The first rapid prototyping therapeutics company

Biotechnology · Boston$550K Grant
Azitra
March 2026

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

Alternative Medicine · Branford$31.0M Post-IPO Equity
Equii
February 2024

Equii is a food technology company tha produces the high-protein grain flours.

Food Processing · San Ramon$200K Seed
Reverb Therapeutics
February 2025

Reverb Therapeutics engages in the development of treatments for cancer and other diseases.

Health Care · Vancouver$12.0M Seed
Dimension Inx
February 2025

Dimension Inx specializes in developing regenerative microenvironments that give the body a blueprint to heal itself.

3D Printing · Chicago$75K Grant
Checkerspot
February 2023

Checkerspot is a biology driven, molecule licensing company designing fats and oils through precision fermentation.

Biotechnology · Alameda$55.0M Series C
Faeth Therapeutics
October 2025

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

Biotechnology · San Francisco$25.0M Series A
Debut
August 2025

Debut is a biotech beauty company that develops biotechnology-based beauty ingredients and formulations.

Beauty · San Diego$20.0M Venture - Series Unknown
Rarebird
February 2025

Rarebird is a coffee company featuring Arabica coffee beans that deliver improved mental wellness outcomes.

Coffee · San Leandro$1.0M Venture - Series Unknown
MacroCycle
February 2025

Circular Plastics. Zero Carbon Emissions.

Plastics and Rubber Manufacturing · Cambridge$6.5M Seed
Terray Therapeutics
October 2024

Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.

Artificial Intelligence (AI) · Monrovia$120.0M Series B
Radar Therapeutics
May 2024

Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.

Medical · Berkeley$13.4M Seed
Elegen
May 2024

Elegen is a biotechnology company that develops microfluidic technology.

Biotechnology · San Carlos$35.0M Series B
Greeneye Technology
April 2024

Greeneye's mission is to dramatically reduce chemical usage while increasing productivity and profitability for farmers.

Agriculture · Tel Aviv$20.0M Venture - Series Unknown
Tierra Biosciences
March 2024

Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.

Artificial Intelligence (AI) · San Leandro$11.4M Series A
Motif Neurotech
January 2024

Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.

Health Care · Houston$18.8M Series A
Aperiam Bio
November 2023

Aperiam Bio partners with enzyme engineers to create and share stabilized, solubilized, and catalytically optimized proteins.

Biotechnology · Austin$9.0M Seed

Where KdT Ventures invests

Biotechnology15
Health Care11
Medical11
Therapeutics6
Life Science5
Artificial Intelligence (AI)4

About KdT Ventures's portfolio

How many companies has KdT Ventures invested in?

KdT Ventures has invested in 57 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does KdT Ventures invest in?

KdT Ventures's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 35 different industry categories.

What is KdT Ventures's largest investment?

Among tracked funding rounds, Terray Therapeutics received $120.0M in a Series B round. KdT Ventures's total known invested capital is $546.9M.

What is the average investment size for KdT Ventures?

KdT Ventures's average investment size is $12.7M across its portfolio of 57 companies.

What are KdT Ventures's most recent investments?

Recent KdT Ventures portfolio additions include Transcera, Modulus Therapeutics, Rejuvenate Bio, Montara Therapeutics, PHNX Materials. These companies were founded in 2020 or later.

Reach the founders behind these 57 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →